1 Introduction to Research & Analysis Reports
1.1 Measles Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Measles Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Measles Vaccine Overall Market Size
2.1 Global Measles Vaccine Market Size: 2022 VS 2029
2.2 Global Measles Vaccine Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Measles Vaccine Sales: 2018-2029
3 Company Landscape
3.1 Top Measles Vaccine Players in Global Market
3.2 Top Global Measles Vaccine Companies Ranked by Revenue
3.3 Global Measles Vaccine Revenue by Companies
3.4 Global Measles Vaccine Sales by Companies
3.5 Global Measles Vaccine Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Measles Vaccine Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Measles Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Measles Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Measles Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Measles Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Measles Vaccine Market Size Markets, 2022 & 2029
4.1.2 Mumps Measles Rubella Vaccine, Live (MMR-II)
4.1.3 Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)
4.2 By Type – Global Measles Vaccine Revenue & Forecasts
4.2.1 By Type – Global Measles Vaccine Revenue, 2018-2023
4.2.2 By Type – Global Measles Vaccine Revenue, 2024-2029
4.2.3 By Type – Global Measles Vaccine Revenue Market Share, 2018-2029
4.3 By Type – Global Measles Vaccine Sales & Forecasts
4.3.1 By Type – Global Measles Vaccine Sales, 2018-2023
4.3.2 By Type – Global Measles Vaccine Sales, 2024-2029
4.3.3 By Type – Global Measles Vaccine Sales Market Share, 2018-2029
4.4 By Type – Global Measles Vaccine Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Measles Vaccine Market Size, 2022 & 2029
5.1.2 Children
5.1.3 Adults
5.2 By Application – Global Measles Vaccine Revenue & Forecasts
5.2.1 By Application – Global Measles Vaccine Revenue, 2018-2023
5.2.2 By Application – Global Measles Vaccine Revenue, 2024-2029
5.2.3 By Application – Global Measles Vaccine Revenue Market Share, 2018-2029
5.3 By Application – Global Measles Vaccine Sales & Forecasts
5.3.1 By Application – Global Measles Vaccine Sales, 2018-2023
5.3.2 By Application – Global Measles Vaccine Sales, 2024-2029
5.3.3 By Application – Global Measles Vaccine Sales Market Share, 2018-2029
5.4 By Application – Global Measles Vaccine Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Measles Vaccine Market Size, 2022 & 2029
6.2 By Region – Global Measles Vaccine Revenue & Forecasts
6.2.1 By Region – Global Measles Vaccine Revenue, 2018-2023
6.2.2 By Region – Global Measles Vaccine Revenue, 2024-2029
6.2.3 By Region – Global Measles Vaccine Revenue Market Share, 2018-2029
6.3 By Region – Global Measles Vaccine Sales & Forecasts
6.3.1 By Region – Global Measles Vaccine Sales, 2018-2023
6.3.2 By Region – Global Measles Vaccine Sales, 2024-2029
6.3.3 By Region – Global Measles Vaccine Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Measles Vaccine Revenue, 2018-2029
6.4.2 By Country – North America Measles Vaccine Sales, 2018-2029
6.4.3 US Measles Vaccine Market Size, 2018-2029
6.4.4 Canada Measles Vaccine Market Size, 2018-2029
6.4.5 Mexico Measles Vaccine Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Measles Vaccine Revenue, 2018-2029
6.5.2 By Country – Europe Measles Vaccine Sales, 2018-2029
6.5.3 Germany Measles Vaccine Market Size, 2018-2029
6.5.4 France Measles Vaccine Market Size, 2018-2029
6.5.5 U.K. Measles Vaccine Market Size, 2018-2029
6.5.6 Italy Measles Vaccine Market Size, 2018-2029
6.5.7 Russia Measles Vaccine Market Size, 2018-2029
6.5.8 Nordic Countries Measles Vaccine Market Size, 2018-2029
6.5.9 Benelux Measles Vaccine Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Measles Vaccine Revenue, 2018-2029
6.6.2 By Region – Asia Measles Vaccine Sales, 2018-2029
6.6.3 China Measles Vaccine Market Size, 2018-2029
6.6.4 Japan Measles Vaccine Market Size, 2018-2029
6.6.5 South Korea Measles Vaccine Market Size, 2018-2029
6.6.6 Southeast Asia Measles Vaccine Market Size, 2018-2029
6.6.7 India Measles Vaccine Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Measles Vaccine Revenue, 2018-2029
6.7.2 By Country – South America Measles Vaccine Sales, 2018-2029
6.7.3 Brazil Measles Vaccine Market Size, 2018-2029
6.7.4 Argentina Measles Vaccine Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Measles Vaccine Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Measles Vaccine Sales, 2018-2029
6.8.3 Turkey Measles Vaccine Market Size, 2018-2029
6.8.4 Israel Measles Vaccine Market Size, 2018-2029
6.8.5 Saudi Arabia Measles Vaccine Market Size, 2018-2029
6.8.6 UAE Measles Vaccine Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 GSK
7.1.1 GSK Company Summary
7.1.2 GSK Business Overview
7.1.3 GSK Measles Vaccine Major Product Offerings
7.1.4 GSK Measles Vaccine Sales and Revenue in Global (2018-2023)
7.1.5 GSK Key News & Latest Developments
7.2 Sanofi-Pasteur
7.2.1 Sanofi-Pasteur Company Summary
7.2.2 Sanofi-Pasteur Business Overview
7.2.3 Sanofi-Pasteur Measles Vaccine Major Product Offerings
7.2.4 Sanofi-Pasteur Measles Vaccine Sales and Revenue in Global (2018-2023)
7.2.5 Sanofi-Pasteur Key News & Latest Developments
7.3 Merck
7.3.1 Merck Company Summary
7.3.2 Merck Business Overview
7.3.3 Merck Measles Vaccine Major Product Offerings
7.3.4 Merck Measles Vaccine Sales and Revenue in Global (2018-2023)
7.3.5 Merck Key News & Latest Developments
7.4 Novartis
7.4.1 Novartis Company Summary
7.4.2 Novartis Business Overview
7.4.3 Novartis Measles Vaccine Major Product Offerings
7.4.4 Novartis Measles Vaccine Sales and Revenue in Global (2018-2023)
7.4.5 Novartis Key News & Latest Developments
7.5 Pfizer
7.5.1 Pfizer Company Summary
7.5.2 Pfizer Business Overview
7.5.3 Pfizer Measles Vaccine Major Product Offerings
7.5.4 Pfizer Measles Vaccine Sales and Revenue in Global (2018-2023)
7.5.5 Pfizer Key News & Latest Developments
7.6 Serum Institute of India
7.6.1 Serum Institute of India Company Summary
7.6.2 Serum Institute of India Business Overview
7.6.3 Serum Institute of India Measles Vaccine Major Product Offerings
7.6.4 Serum Institute of India Measles Vaccine Sales and Revenue in Global (2018-2023)
7.6.5 Serum Institute of India Key News & Latest Developments
7.7 China National Biotech Group
7.7.1 China National Biotech Group Company Summary
7.7.2 China National Biotech Group Business Overview
7.7.3 China National Biotech Group Measles Vaccine Major Product Offerings
7.7.4 China National Biotech Group Measles Vaccine Sales and Revenue in Global (2018-2023)
7.7.5 China National Biotech Group Key News & Latest Developments
7.8 Bavarian Nordic
7.8.1 Bavarian Nordic Company Summary
7.8.2 Bavarian Nordic Business Overview
7.8.3 Bavarian Nordic Measles Vaccine Major Product Offerings
7.8.4 Bavarian Nordic Measles Vaccine Sales and Revenue in Global (2018-2023)
7.8.5 Bavarian Nordic Key News & Latest Developments
7.9 Emergent Biosolutions
7.9.1 Emergent Biosolutions Company Summary
7.9.2 Emergent Biosolutions Business Overview
7.9.3 Emergent Biosolutions Measles Vaccine Major Product Offerings
7.9.4 Emergent Biosolutions Measles Vaccine Sales and Revenue in Global (2018-2023)
7.9.5 Emergent Biosolutions Key News & Latest Developments
7.10 Medimmune
7.10.1 Medimmune Company Summary
7.10.2 Medimmune Business Overview
7.10.3 Medimmune Measles Vaccine Major Product Offerings
7.10.4 Medimmune Measles Vaccine Sales and Revenue in Global (2018-2023)
7.10.5 Medimmune Key News & Latest Developments
7.11 Johnson & Johnson
7.11.1 Johnson & Johnson Company Summary
7.11.2 Johnson & Johnson Measles Vaccine Business Overview
7.11.3 Johnson & Johnson Measles Vaccine Major Product Offerings
7.11.4 Johnson & Johnson Measles Vaccine Sales and Revenue in Global (2018-2023)
7.11.5 Johnson & Johnson Key News & Latest Developments
7.12 CSL Limited
7.12.1 CSL Limited Company Summary
7.12.2 CSL Limited Measles Vaccine Business Overview
7.12.3 CSL Limited Measles Vaccine Major Product Offerings
7.12.4 CSL Limited Measles Vaccine Sales and Revenue in Global (2018-2023)
7.12.5 CSL Limited Key News & Latest Developments
8 Global Measles Vaccine Production Capacity, Analysis
8.1 Global Measles Vaccine Production Capacity, 2018-2029
8.2 Measles Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Measles Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Measles Vaccine Supply Chain Analysis
10.1 Measles Vaccine Industry Value Chain
10.2 Measles Vaccine Upstream Market
10.3 Measles Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Measles Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
世界の麻疹ワクチン市場予測2023-2029：おたふく風邪・麻疹・風疹生ワクチン（MMR-II）、おたふく風邪・麻疹・風疹・水痘ウイルスワクチン（Proquad） |
| 【英語タイトル】Measles Vaccine Market, Global Outlook and Forecast 2023-2029 | |
 | ・商品コード：MMG23JU5740 ・発行会社（調査会社）：Market Monitor Global ・発行日：2023年6月 ・ページ数：73 ・レポート言語：英語 ・レポート形式：PDF ・納品方法：Eメール（受注後2-3営業日） ・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど ・産業分野：医薬品＆医療 |
| Single User（1名様閲覧用） | USD3,250 ⇒換算￥494,000 | 見積依頼/購入/質問フォーム |
| Multi User（20名様閲覧用） | USD4,225 ⇒換算￥642,200 | 見積依頼/購入/質問フォーム |
| Enterprise User（閲覧人数制限なし） | USD4,875 ⇒換算￥741,000 | 見積依頼/購入/質問フォーム |
|
※販売価格オプションの説明 ※お支払金額：換算金額（日本円）＋消費税 ※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡） ※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能） |
| 当調査レポートは次の情報を含め、世界の麻疹ワクチン市場規模と予測を収録しています。・世界の麻疹ワクチン市場：売上、2018年-2023年、2024年-2029年 ・世界の麻疹ワクチン市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の麻疹ワクチン市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「おたふく風邪・麻疹・風疹生ワクチン（MMR-II）」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 麻疹ワクチンのグローバル主要企業は、GSK、 Sanofi-Pasteur、 Merck、 Novartis、 Pfizer、 Serum Institute of India、 China National Biotech Group、 Bavarian Nordic、 Emergent Biosolutions、 Medimmune、 Johnson & Johnson、 CSL Limitedなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、麻疹ワクチンのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の麻疹ワクチン市場：タイプ別、2018年-2023年、2024年-2029年 世界の麻疹ワクチン市場：タイプ別市場シェア、2022年 ・おたふく風邪・麻疹・風疹生ワクチン（MMR-II）、おたふく風邪・麻疹・風疹・水痘ウイルスワクチン（Proquad） 世界の麻疹ワクチン市場：用途別、2018年-2023年、2024年-2029年 世界の麻疹ワクチン市場：用途別市場シェア、2022年 ・子供、大人 世界の麻疹ワクチン市場：地域・国別、2018年-2023年、2024年-2029年 世界の麻疹ワクチン市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における麻疹ワクチンのグローバル売上、2018年-2023年 ・主要企業における麻疹ワクチンのグローバル売上シェア、2022年 ・主要企業における麻疹ワクチンのグローバル販売量、2018年-2023年 ・主要企業における麻疹ワクチンのグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 GSK、 Sanofi-Pasteur、 Merck、 Novartis、 Pfizer、 Serum Institute of India、 China National Biotech Group、 Bavarian Nordic、 Emergent Biosolutions、 Medimmune、 Johnson & Johnson、 CSL Limited ************************************************************* ・調査・分析レポートの概要 麻疹ワクチン市場の定義 市場セグメント 世界の麻疹ワクチン市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の麻疹ワクチン市場規模 世界の麻疹ワクチン市場規模：2022年 VS 2029年 世界の麻疹ワクチン市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの麻疹ワクチンの売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の麻疹ワクチン製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：おたふく風邪・麻疹・風疹生ワクチン（MMR-II）、おたふく風邪・麻疹・風疹・水痘ウイルスワクチン（Proquad） 麻疹ワクチンのタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：子供、大人 麻疹ワクチンの用途別グローバル売上・予測 ・地域別市場分析 地域別麻疹ワクチン市場規模 2022年と2029年 地域別麻疹ワクチン売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） GSK、 Sanofi-Pasteur、 Merck、 Novartis、 Pfizer、 Serum Institute of India、 China National Biotech Group、 Bavarian Nordic、 Emergent Biosolutions、 Medimmune、 Johnson & Johnson、 CSL Limited ... |
This report aims to provide a comprehensive presentation of the global market for Measles Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Measles Vaccine. This report contains market size and forecasts of Measles Vaccine in global, including the following market information:
Global Measles Vaccine Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Measles Vaccine Market Sales, 2018-2023, 2024-2029, (K MT)
Global top five Measles Vaccine companies in 2022 (%)
The global Measles Vaccine market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Mumps Measles Rubella Vaccine, Live (MMR-II) Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Measles Vaccine include GSK, Sanofi-Pasteur, Merck, Novartis, Pfizer, Serum Institute of India, China National Biotech Group, Bavarian Nordic and Emergent Biosolutions, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Measles Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Measles Vaccine Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K MT)
Global Measles Vaccine Market Segment Percentages, by Type, 2022 (%)
Mumps Measles Rubella Vaccine, Live (MMR-II)
Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)
Global Measles Vaccine Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K MT)
Global Measles Vaccine Market Segment Percentages, by Application, 2022 (%)
Children
Adults
Global Measles Vaccine Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K MT)
Global Measles Vaccine Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Measles Vaccine revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Measles Vaccine revenues share in global market, 2022 (%)
Key companies Measles Vaccine sales in global market, 2018-2023 (Estimated), (K MT)
Key companies Measles Vaccine sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
GSK
Sanofi-Pasteur
Merck
Novartis
Pfizer
Serum Institute of India
China National Biotech Group
Bavarian Nordic
Emergent Biosolutions
Medimmune
Johnson & Johnson
CSL Limited
Outline of Major Chapters:
Chapter 1: Introduces the definition of Measles Vaccine, market overview.
Chapter 2: Global Measles Vaccine market size in revenue and volume.
Chapter 3: Detailed analysis of Measles Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Measles Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Measles Vaccine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
❖ レポートの目次 ❖
| ★調査レポート[世界の麻疹ワクチン市場予測2023-2029：おたふく風邪・麻疹・風疹生ワクチン（MMR-II）、おたふく風邪・麻疹・風疹・水痘ウイルスワクチン（Proquad）] (コード：MMG23JU5740)販売に関する免責事項を必ずご確認ください。 |
| ★調査レポート[世界の麻疹ワクチン市場予測2023-2029：おたふく風邪・麻疹・風疹生ワクチン（MMR-II）、おたふく風邪・麻疹・風疹・水痘ウイルスワクチン（Proquad）]についてメールでお問い合わせ |
